Management of Coats disease with bevacizumab in 2 patients

Can J Ophthalmol. 2008 Apr;43(2):245-6. doi: 10.3129/i08-028.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Exudates and Transudates
  • Female
  • Fluorescein Angiography
  • Humans
  • Injections
  • Macular Edema / drug therapy
  • Retinal Diseases / diagnosis
  • Retinal Diseases / drug therapy*
  • Retinal Vessels / drug effects*
  • Retinal Vessels / pathology
  • Telangiectasis / diagnosis
  • Telangiectasis / drug therapy*
  • Tomography, Optical Coherence
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Visual Acuity
  • Vitreous Body

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Vascular Endothelial Growth Factor A
  • Bevacizumab